LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: COVID-19-associated myoclonus in a series of five critically ill patients.

Grieb, Alexander / Seitz, Tamara / Kitzberger, Reinhard / Schmidbauer, Manfred / Hoepler, Wolfgang / Baumgartner, Sebastian / Traugott, Marianna T / Pawelka, Erich / Karolyi, Mario / Strasser, Georg / Knibbe, Karolina / Laferl, Hermann / Zoufaly, Alexander / Wenisch, Christoph / Neuhold, Stephanie

Wiener klinische Wochenschrift

2021  Volume 133, Issue 17-18, Page(s) 902–908

Abstract: ... critically ill patients with COVID-19-associated myoclonus.: Material and methods: The clinical courses and ... myoclonus in five patients suffering from the disease. The purpose of this article is to report on five ... In severe cases of COVID-19 myoclonus can manifest about 3 weeks after initial onset of symptoms. Sedation ...

Abstract Background: In addition to respiratory symptoms, many patients with coronavirus disease 2019 (COVID-19) present with neurological complications. Several case reports and small case series described myoclonus in five patients suffering from the disease. The purpose of this article is to report on five critically ill patients with COVID-19-associated myoclonus.
Material and methods: The clinical courses and test results of patients treated in the study center ICU and those of partner hospitals are described. Imaging, laboratory tests and electrophysiological test results are reviewed and discussed.
Results: In severe cases of COVID-19 myoclonus can manifest about 3 weeks after initial onset of symptoms. Sedation is sometimes effective for symptom control but impedes respiratory weaning. No viral particles or structural lesions explaining this phenomenon were found in this cohort.
Conclusion: Myoclonus in patients with severe COVID-19 may be due to an inflammatory process, hypoxia or GABAergic impairment. Most patients received treatment with antiepileptic or anti-inflammatory agents and improved clinically.
MeSH term(s) COVID-19 ; Critical Illness ; Humans ; Intensive Care Units ; Myoclonus/chemically induced ; Myoclonus/diagnosis ; Myoclonus/drug therapy ; SARS-CoV-2
Language English
Publishing date 2021-06-15
Publishing country Austria
Document type Journal Article
ZDB-ID 200462-8
ISSN 1613-7671 ; 0043-5325 ; 0300-5178
ISSN (online) 1613-7671
ISSN 0043-5325 ; 0300-5178
DOI 10.1007/s00508-021-01890-3
Shelf mark
Zs.A 902: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top